These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3918784)
1. Effects of synthetic analogues of teleocidin, indolactam-V, on the differentiation of murine pre-adipose cells. Sato M; Hiragun A; Shudo K Cancer Lett; 1985 Jan; 25(3):261-9. PubMed ID: 3918784 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship in the induction of Epstein-Barr virus by teleocidin derivatives. Irie K; Tokuda H; Hagiwara N; Koshimizu K; Hayashi H; Murao S; Ito Y Int J Cancer; 1985 Oct; 36(4):485-8. PubMed ID: 2995261 [TBL] [Abstract][Full Text] [Related]
3. Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promoters. Hirota M; Suganuma M; Yoshizawa S; Horiuchi T; Nakayasu M; Hasegawa M; Endo Y; Shudo K; Fujiki H Jpn J Cancer Res; 1987 Jun; 78(6):577-82. PubMed ID: 3112073 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies on synthetic analogues (indolactams) of the tumor promoter teleocidin. Fujiki H; Suganuma M; Nakayasu M; Tahira T; Endo Y; Shudo K; Sugimura T Gan; 1984 Oct; 75(10):866-70. PubMed ID: 6595181 [TBL] [Abstract][Full Text] [Related]
5. Enzymatic Formation of Indolactam Scaffold by C-N Bond-Forming Cytochrome P450 Oxidases in Teleocidin Biosynthesis. Morita I; Mori T; Abe I Chemistry; 2021 Feb; 27(9):2963-2972. PubMed ID: 32996659 [TBL] [Abstract][Full Text] [Related]
6. Synthetic Indolactam V Analogues as Inhibitors of PAR2-Induced Calcium Mobilization in Triple-Negative Breast Cancer Cells. Stein J; Stahn S; Neudörfl JM; Sperlich J; Schmalz HG; Teusch N ChemMedChem; 2018 Jan; 13(2):147-154. PubMed ID: 29195005 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activities of (-)-6-n-octyl-indolactam-V, a new potent analogue of the tumor promoter (-)-indolactam-V. Nakagawa Y; Irie K; Nakamura Y; Ohigashi H; Hayashi H Biosci Biotechnol Biochem; 1998 Aug; 62(8):1568-73. PubMed ID: 9757563 [TBL] [Abstract][Full Text] [Related]
8. Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-benzolactam-V8-310. Okabe S; Sueoka N; Komori A; Suganuma M; Endo Y; Shudo K; Fujiki H Biol Pharm Bull; 1998 May; 21(5):465-8. PubMed ID: 9635501 [TBL] [Abstract][Full Text] [Related]
9. Pendolmycin, a new tumor promoter of the teleocidin A class on skin of CD-1 mice. Nishiwaki S; Fujiki H; Yoshizawa S; Suganuma M; Furuya-Suguri H; Okabe S; Nakayasu M; Okabe K; Muratake H; Natsume M Jpn J Cancer Res; 1991 Jul; 82(7):779-83. PubMed ID: 1908844 [TBL] [Abstract][Full Text] [Related]
10. Similar, potent tumor-promoting activity of all isomers of teleocidins A and B in a two-stage carcinogenesis experiment on the skin of CD-1 mice. Fujiki H; Suganuma M; Ninomiya M; Yoshizawa S; Yamashita K; Takayama S; Hitotsuyanagi Y; Sakai S; Shudo K; Sugimura T Cancer Res; 1988 Aug; 48(15):4211-4. PubMed ID: 3134123 [TBL] [Abstract][Full Text] [Related]
11. Nakahara memorial lecture. New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin. Fujiki H; Suganuma M; Tahira T; Yoshioka A; Nakayasu M; Endo Y; Shudo K; Takayama S; Moore RE; Sugimura T Princess Takamatsu Symp; 1983; 14():37-45. PubMed ID: 6151565 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity studies of the indole alkaloid tumor promoter teleocidins. Irie K; Hagiwara N; Tokuda H; Koshimizu K Carcinogenesis; 1987 Apr; 8(4):547-52. PubMed ID: 3103947 [TBL] [Abstract][Full Text] [Related]
14. Solid-phase synthesis and biological evaluation of a teleocidin library--discovery of a selective PKCdelta down regulator. Meseguer B; Alonso-Díaz D; Griebenow N; Herget T; Waldmann H Chemistry; 2000 Nov; 6(21):3943-57. PubMed ID: 11126955 [TBL] [Abstract][Full Text] [Related]
15. Structure, biosynthesis and activity of indolactam alkaloids. Pearson LA; Karuso P; Neilan BA Alkaloids Chem Biol; 2024; 92():1-45. PubMed ID: 39384253 [TBL] [Abstract][Full Text] [Related]
16. Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation. Endo Y; Takehana S; Ohno M; Driedger PE; Stabel S; Mizutani MY; Tomioka N; Itai A; Shudo K J Med Chem; 1998 Apr; 41(9):1476-96. PubMed ID: 9554881 [TBL] [Abstract][Full Text] [Related]
17. Studies on olivoretins indicate a requirement for a free hydroxyl group for teleocidin B activity. Horiuchi T; Fujiki H; Suganuma M; Hakii H; Nakayasu M; Hitotsuyanagi Y; Aimi N; Sakai S; Endo Y; Shudo K Gan; 1984 Oct; 75(10):837-40. PubMed ID: 6439591 [TBL] [Abstract][Full Text] [Related]
18. Biosynthesis of the teleocidin-type terpenoid indole alkaloids. Awakawa T; Abe I Org Biomol Chem; 2018 Jul; 16(26):4746-4752. PubMed ID: 29774913 [TBL] [Abstract][Full Text] [Related]
19. Enhancing effect of tumor promoters, phorbol esters and teleocidins on nuclear receptor-mediated transcription. Fukasawa H; Yamaguchi M; Hashimoto Y; Endo Y; Shudo K Biol Pharm Bull; 2000 Dec; 23(12):1414-7. PubMed ID: 11145168 [TBL] [Abstract][Full Text] [Related]
20. 11-Step Total Synthesis of Teleocidins B-1-B-4. Nakamura H; Yasui K; Kanda Y; Baran PS J Am Chem Soc; 2019 Jan; 141(4):1494-1497. PubMed ID: 30636411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]